$PG · The Procter & Gamble Company SEC Filings
Position Tracker tracks 11 SEC EDGAR filings for The Procter & Gamble Company ($PG) from October 26, 2026 through November 6, 2026, including 0 Form 10-K annual reports, 0 Form 10-Q quarterly earnings reports, 2 Form 8-K current event disclosures, and 6 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$PG 25-NSE — The Procter & Gamble Company
The New York Stock Exchange LLC filed a Form 25 with the Securities and Exchange Commission on November 6, 2026, regarding The Procter & Gamble Company. The filing notifies the…
$PG CERT — The Procter & Gamble Company
The filing is a CERT form from The Procter & Gamble Company, dated November 5, 2026. CERT filings are typically certifications required under SEC rules, often related to the acc…
$PG 4 — The Procter & Gamble Company
The Procter & Gamble Company filed a Form 4 with the SEC on November 5, 2026, reporting transactions by Chief Financial Officer Andre Schulten. According to the filing, on Novem…
$PG 8-A12B — The Procter & Gamble Company
The Procter & Gamble Company filed Form 8-A with the SEC to register four series of debt securities under Section 12(b) of the Securities Exchange Act of 1934. The securities ar…
$PG 8-K — The Procter & Gamble Company
The Procter & Gamble Company filed a current report on Form 8-K dated November 3, 2026, announcing the completion of an underwritten public offering of euro-denominated senior n…
$PG 4 — The Procter & Gamble Company
On November 3, 2026, Matthew W. Janzaruk, Senior Vice President and Chief Accounting Officer of The Procter & Gamble Company, reported transactions in PG common stock on a Form…
$PG 4 — The Procter & Gamble Company
The Procter & Gamble Company filed a Form 4 with the SEC on November 3, 2026, reporting a change in beneficial ownership by Paul Gama, who is identified as CEO – Health Care. Th…
$PG 4 — The Procter & Gamble Company
The Procter & Gamble Company filed a Form 4 disclosing transactions by Moses Victor Javier Aguilar, the company’s Chief Research, Development & Innovation Officer. On October 30…
$PG 4 — The Procter & Gamble Company
The Procter & Gamble Company filed a Form 4 with the SEC on November 3, 2026, reporting transactions by Sundar G. Raman, an officer of the company serving as CEO of Fabric & Hom…
$PG 8-K — The Procter & Gamble Company
On November 2, 2026, The Procter & Gamble Company filed a current report on Form 8-K announcing that it had closed an underwritten public offering of $352,231,000 aggregate prin…
$PG 4 — PROCTER & GAMBLE Co
A CEO option exercise-and-sell is routine compensation monetization, not a directional signal.